Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    DERMATITIS, ATOPIC, 6
Show Display Options
Rank Status Study
1 Recruiting Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2%
Condition: Atopic Dermatitis
Intervention: Drug: MRX-6
2 Completed Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream
Condition: Dermatitis, Atopic
Intervention: Drug: WBI-1001
3 Terminated Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
Condition: Atopic Dermatitis
Interventions: Drug: LEO 29102;   Drug: LEO 29102 Cream Vehicle

Indicates status has not been verified in more than two years